PDFWAC 246-101-101
Notifiable conditions—Health care providers and health care facilities.
(1) For the purposes of this section:
(a) "Local health jurisdiction" means where the patient resides, or, in the event the patient's residence cannot be determined, the local health jurisdiction in which the patient received treatment.
(b) "Unexplained critical illness or death" means a severe illness or death with infectious hallmarks, but no known etiology, in a previously healthy person one to forty-nine years of age excluding those with chronic medical conditions such as malignancy, diabetes, AIDS, or cirrhosis.
(2) The conditions identified in Table HC-1 are notifiable to public health authorities under this table and this chapter.
Table HC-1 (Conditions Notifiable by Health Care Providers and Health Care Facilities)
Notifiable Condition (Agent) | Laboratory Confirmation Required Before Submitting Case Report | Time Frame for Notification from Identification of a Case | Who Must Be Notified | Who Must Report: Health Care Providers (Providers) or Health Care Facilities (Facilities) |
Acquired immunodeficiency syndrome (AIDS) | Within 3 business days | DOH (for facilities) and LHJ (for providers) | Both | |
Amebic meningitis | Immediately | LHJ | Both | |
Anaplasmosis | Within 3 business days | LHJ | Both | |
Anthrax (Bacillus anthracis and confirmed Bacillus cereus biovar anthracis only - Do not report all Bacillus cereus) | Yes | Immediately | LHJ | Both |
Arboviral disease (acute disease only) including, but not limited to: Chikungunya Dengue Eastern and western equine encephalitis Japanese encephalitis La Crosse encephalitis Powassan virus infection St. Louis encephalitis West Nile virus infection Zika virus infection See also "Yellow fever" | Within 3 business days | LHJ | Both | |
Asthma, occupational | Within 30 days | Washington state department of labor and industries (L&I) | Both | |
Babesiosis | Within 3 business days | LHJ | Both | |
Baylisascariasis | Within 24 hours | LHJ | Both | |
Birth defects - Abdominal wall defects (inclusive of gastroschisis and omphalocele) | Within 30 days | DOH | Facilities | |
Birth defects - Autism spectrum disorders | Within 30 days | DOH | Both | |
Birth defects - Cerebral palsy | Within 30 days | DOH | Both | |
Birth defects - Down syndrome | Within 30 days | DOH | Facilities | |
Birth defects - Alcohol related birth defects | Within 30 days | DOH | Both | |
Birth defects - Hypospadias | Within 30 days | DOH | Facilities | |
Birth defects - Limb reductions | Within 30 days | DOH | Facilities | |
Birth defects - Neural tube defects (inclusive of anencephaly and spina bifida) | Within 30 days | DOH | Facilities | |
Birth defects - Oral clefts (inclusive of cleft lip with/without cleft palate) | Within 30 days | DOH | Facilities | |
Blood lead level RST results (See WAC 246-101-200) | Providers and facilities performing blood lead level RST shall report as a laboratory and comply with the requirements of WAC 246-101-201 through 246-101-230. | |||
Botulism, foodborne, infant, and wound | Immediately | LHJ | Both | |
Brucellosis | Within 24 hours | LHJ | Both | |
Campylobacteriosis | Within 3 business days | LHJ | Both | |
Cancer (See chapter 246-102 WAC) | ||||
Candida auris infection or colonization | Within 24 hours | LHJ | Both | |
Carbapenem-resistant Enterobacteriaceae infections limited to: Klebsiella species E. coli Enterobacter species | Yes | Within 3 business days | LHJ | Both |
Chagas disease | Within 3 business days | LHJ | Both | |
Chancroid | Within 3 business days | LHJ | Both | |
Chlamydia trachomatis infection | Yes | Within 3 business days | LHJ | Both |
Cholera (Vibrio cholerae O1 or O139) | Yes | Immediately | LHJ | Both |
Coccidioidomycosis | Within 3 business days | LHJ | Both | |
Coronavirus infection (severe communicable) SARS-associated coronavirus MERS-associated coronavirus Novel coronavirus (COVID-19) | Yes | Immediately | LHJ | Both |
Coronavirus infection (severe communicable) Novel coronavirus (COVID-19) RST results (See WAC 246-101-200) | Providers and facilities performing Novel coronavirus (COVID-19) RST shall report as a laboratory and comply with the requirements of WAC 246-101-201 through 246-101-230. | |||
Cryptococcus gattii or undifferentiated Cryptococcus species (i.e., Cryptococcus not identified as C. neoformans) | Yes | Within 3 business days | LHJ | Both |
Cryptosporidiosis | Within 3 business days | LHJ | Both | |
Cyclosporiasis | Within 3 business days | LHJ | Both | |
Cysticercosis | Within 3 business days | LHJ | Both | |
Diphtheria | Immediately | LHJ | Both | |
Domoic acid poisoning | Immediately | LHJ | Both | |
E. coli (See "Shiga toxin-producing E. coli") | ||||
Echinococcosis | Within 3 business days | LHJ | Both | |
Ehrlichiosis | Within 3 business days | LHJ | Both | |
Giardiasis | Within 3 business days | LHJ | Both | |
Glanders (Burkholderia mallei) | Yes | Immediately | LHJ | Both |
Gonorrhea | Within 3 business days | LHJ | Both | |
Granuloma inguinale | Within 3 business days | LHJ | Both | |
Gunshot wounds (nonfatal) | Within 30 days | DOH | Facilities | |
Haemophilus influenzae (invasive disease, children under 5 years of age) | Yes | Immediately | LHJ | Both |
Hantaviral infection | Within 24 hours | LHJ | Both | |
Hepatitis A (acute infection) | Yes | Within 24 hours | LHJ | Both |
Hepatitis B (acute infection) | Yes | Within 24 hours | LHJ | Both |
Hepatitis B, report pregnancy in hepatitis B virus infected patients (including carriers) | Yes | Within 3 business days | LHJ | Both |
Hepatitis B (chronic infection) - Initial diagnosis, and previously unreported prevalent cases | Yes | Within 3 business days | LHJ | Both |
Hepatitis B (perinatal) - Initial diagnosis, and previously unreported cases | Yes | Within 3 business days | LHJ | Both |
Hepatitis C (acute infection) | Yes | Within 24 hours | LHJ | Both |
Hepatitis C (acute infection) RST results (See WAC 246-101-200) | Providers and facilities performing hepatitis C (acute infection) RST shall report as a laboratory and comply with the requirements of WAC 246-101-201 through 246-101-230. | |||
Hepatitis C (chronic infection) | Yes | Within 3 business days | LHJ | Both |
Hepatitis C (perinatal) - Initial diagnosis, and previously unreported cases | Yes | Within 24 hours | LHJ | Both |
Hepatitis C (chronic infection) RST results (See WAC 246-101-200) | Providers and facilities performing hepatitis C (chronic infection) RST shall report as a laboratory and comply with the requirements of WAC 246-101-201 through 246-101-230. | |||
Hepatitis D (acute and chronic infection) | Yes | Within 24 hours | LHJ | Both |
Hepatitis E (acute infection) | Yes | Within 24 hours | LHJ | Both |
Herpes simplex, neonatal and genital (initial infection only) | Within 3 business days | LHJ | Providers | |
Histoplasmosis | Within 3 business days | LHJ | Both | |
Human immunodeficiency virus (HIV) infection | Within 3 business days | LHJ | Both | |
Human immunodeficiency virus (HIV) infection RST results (See WAC 246-101-200) | Providers and facilities performing HIV infection RST shall report as a laboratory and comply with the requirements of WAC 246-101-201 through 246-101-230. | |||
Human prion disease | Within 3 business days | LHJ | Both | |
Hypersensitivity pneumonitis, occupational | Within 30 days | L&I | Both | |
Influenza, novel or unsubtypable strain | Immediately | LHJ | Both | |
Influenza-associated death (laboratory confirmed) | Yes | Within 3 business days | LHJ | Both |
Legionellosis | Within 24 hours | LHJ | Both | |
Leptospirosis | Within 24 hours | LHJ | Both | |
Listeriosis | Within 24 hours | LHJ | Both | |
Lyme disease | Within 3 business days | LHJ | Both | |
Lymphogranuloma venereum | Within 3 business days | LHJ | Both | |
Malaria | Within 3 business days | LHJ | Both | |
Measles (rubeola) - Acute disease only | Immediately | LHJ | Both | |
Melioidosis (Burkholderia pseudomallei) | Yes | Immediately | LHJ | Both |
Meningococcal disease, invasive | Immediately | LHJ | Both | |
Monkeypox | Immediately | LHJ | Both | |
Mumps, acute disease only | Within 24 hours | LHJ | Both | |
Outbreaks and suspected outbreaks | Immediately | LHJ | Both | |
Paralytic shellfish poisoning | Immediately | LHJ | Both | |
Pertussis | Within 24 hours | LHJ | Both | |
Pesticide poisoning (hospitalized, fatal, or cluster) | Immediately | DOH | Both | |
Pesticide poisoning (all other) | Within 3 business days | DOH | Both | |
Plague | Immediately | LHJ | Both | |
Poliomyelitis | Immediately | LHJ | Both | |
Pregnancy in patient with hepatitis B virus | See "Hepatitis B, report pregnancy in hepatitis B virus infected patients (including carriers)" | |||
Psittacosis | Within 24 hours | LHJ | Both | |
Q fever | Within 24 hours | LHJ | Both | |
Rabies (suspect or laboratory confirmed human cases and laboratory confirmed animal cases) | Yes for animal cases | Immediately | LHJ | Both |
Rabies, suspected human exposure (suspected human rabies exposures due to a bite from or other exposure to an animal that is suspected of being infected with rabies) | Immediately | LHJ | Both | |
Relapsing fever (borreliosis) | Within 3 business days | LHJ | Both | |
Rickettsia infection | Within 3 business days | LHJ | Both | |
Rubella, acute disease only (including congenital rubella syndrome) | Immediately | LHJ | Both | |
Salmonellosis | Within 24 hours | LHJ | Both | |
Serious adverse reactions to immunizations | Within 3 business days | LHJ | Both | |
Shiga toxin-producing E. coli (STEC) infections/enterohemorrhagic E. coli infections | Yes | Immediately | LHJ | Both |
Shigellosis | Within 24 hours | LHJ | Both | |
Silicosis | Within 30 days | L&I | Both | |
Smallpox | Immediately | LHJ | Both | |
Syphilis | Within 3 business days | LHJ | Both | |
Taeniasis | Within 3 business days | LHJ | Both | |
Tetanus | Within 3 business days | LHJ | Both | |
Tick paralysis | Within 3 business days | LHJ | Both | |
Trichinosis | Within 3 business days | LHJ | Both | |
Tuberculosis disease (confirmed or highly suspicious, i.e., initiation of empiric treatment) | Within 24 hours | LHJ | Both | |
Tularemia | Immediately | LHJ | Both | |
Typhus | Within 3 business days | LHJ | Both | |
Vaccinia transmission | Immediately | LHJ | Both | |
Vancomycin-resistant Staphylococcus aureus (not to include vancomycin-intermediate) | Yes | Within 24 hours | LHJ | Both |
Varicella-associated death | Within 3 business days | LHJ | Both | |
Vibriosis (Vibrio species not including Vibrio cholerae O1 or O139) See Cholera (Vibrio cholerae O1 or O139) | Yes | Within 24 hours | LHJ | Both |
Viral hemorrhagic fever | Immediately | LHJ | Both | |
Yellow fever | Immediately | LHJ | Both | |
Yersiniosis | Within 24 hours | LHJ | Both | |
Unexplained critical illness or death | Within 24 hours | LHJ | Both | |
[Statutory Authority: RCW 43.20.050, 70.28.032, 70.104.055, 43.70.545, and 70.24.130. WSR 21-11-040 and 22-01-175, § 246-101-101, filed 5/12/21 and 12/17/21, effective 1/1/23. Statutory Authority: RCW 43.20.050. WSR 11-02-065, § 246-101-101, filed 1/4/11, effective 2/4/11. Statutory Authority: RCW 43.20.050, 70.24.125. WSR 05-03-055, § 246-101-101, filed 1/11/05, effective 2/11/05. Statutory Authority: RCW 43.20.050, 70.24.125 and 70.28.010. WSR 00-23-120, § 246-101-101, filed 11/22/00, effective 12/23/00.]